TORNTPHARM

: A Quiet Compounder in Indian Pharma 💊📈

Founded in 1959 and headquartered in Ahmedabad,

Torrent Pharma has evolved from a domestic formulations player into a global branded generics powerhouse. Strategic acquisitions like Heumann (Germany), Elder Pharma India, and Unichem’s domestic business strengthened its India and Europe footprint. After navigating regulatory challenges in 2018–19, the company tightened compliance, increased R&D focus, and sharpened its chronic therapy portfolio. With FY25 revenue crossing ₹11,500+ crore and the JB Pharma acquisition (June 2025) boosting its growth runway, Torrent continues positioning itself for steady long-term compounding.